Unraveling the protein post-translational modification landscape: Neuroinflammation and neuronal death after stroke

Jin Tao1, Jiaxin Li2, Xiaochong Fan3

  • 1Department of Pain Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P. R. China; Department of Human Anatomy, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, P. R. China.

Ageing Research Reviews
|September 14, 2024
PubMed

Insights

Post-translational modifications (PTMs) are key regulators of brain injury in stroke, including cerebral ischemia, intracerebral hemorrhage (ICH), and subarachnoid hemorrhage (SAH). Understanding PTMs offers new therapeutic avenues for stroke.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Stroke, encompassing cerebral ischemia, intracerebral hemorrhage (ICH), and subarachnoid hemorrhage (SAH), poses a significant global health burden due to high mortality and morbidity.
  • Stroke pathophysiology involves secondary damage and irreversible neuronal dysfunction.
  • Post-translational modifications (PTMs) are increasingly recognized as critical regulators in brain injury following ischemic and hemorrhagic stroke.

Purpose of the Study:

  • To comprehensively review the landscape of PTMs in neuroinflammation and neuronal death relevant to cerebral ischemia, ICH, and SAH.
  • To elucidate the role of PTMs in regulating pathological mechanisms underlying stroke.
  • To present key techniques and proteomic strategies for PTM identification.

Main Methods:

  • Literature review of recent research on PTMs in stroke.
  • Analysis of PTMs including phosphorylation, glycosylation, ubiquitination, SUMOylation, acetylation, and succinylation.
  • Discussion of proteomic strategies for PTM identification.

Main Results:

  • PTMs play a crucial role in regulating neuroinflammation and neuronal death in various stroke types.
  • Specific PTMs are implicated in the complex pathophysiology of ischemic and hemorrhagic stroke.
  • Proteomic approaches are vital for identifying and understanding the functional significance of PTMs in stroke.

Conclusions:

  • Exploring the PTM landscape is essential for comprehending stroke pathophysiology, injury, and repair mechanisms.
  • Understanding PTMs can facilitate the development of novel therapeutic strategies for stroke.
  • This review highlights the critical importance of PTMs in stroke research and clinical applications.

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
54
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28